INSP logo

INSPIRE MEDICAL SYSTEMS INC

INSPNYSE
πŸ† #1884 by market capUS Equity
$71.08β–² $0.11 (+0.15%)
Market closed Β· at close
πŸ””
Track INSP
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 0.1%
7dβ–² 0.0%
14dβ–² 3.7%
30dβ–² 2.1%
ytdβ–Ό 22.9%
1yβ–Ό 2.7%
🏦Market Cap
$2.05B
Small Cap
πŸ“ˆRevenue Growth (YoY)
4.3%
Slowing
πŸ“ŠGross Margin
86.1%
High
πŸ’΅FCF Margin
13.0%
Healthy
βš–οΈP/S Ratio
2.3x
Cheap
Otter Score
76
Strong

Trading Snapshot

Day Range
$70.56 – $71.66
52-Week Range
$38.91 – $147.03
Volume (shares)
27,718
Avg Volume (shares)
β€”
Shares Outstanding
28.9M
Next Earnings
β€”

Fundamentals Snapshot

Annual Revenue
$912M
Last Q Revenue
$201M
P/E Ratio
15.1
P/S Ratio
2.3x
EPS (TTM)
$4.61
Dividend Yield
β€”
Dilution (1yr)
βˆ’5.0%
INSP logo

INSPIRE MEDICAL SYSTEMS INC

INSP
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$912Mβ–² +13.6% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
85.4%β–² +0.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$51Mβ–² +41.2% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$78Mβ–Ό βˆ’13.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
29.2Mβ–Ό βˆ’5.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$43Mβ–Ό βˆ’$76M YoY
StockOtter Β· stockotter.space

About INSPIRE MEDICAL SYSTEMS INC

Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Strong
76/100
Analyst data unavailable.

Latest News & Updates

News unavailable.